Studies have found hypermethylation in the promoter region of HDAC4 in the peripheral blood of PD-MCI patients, leading to decreased expression, which is also linked to reduced synaptophysin in the frontal cortex. This evidence concerns the gene HDAC4 and Parkinson disease.